ONDINE BIOPHARMA CORP

Profile

Company Names

ONDINE BIOPHARMA CORP

Addresses

910-1100 MELVILLE ST, VANCOUVER, A1 V6E 4A6

Phone Numbers

604-669-0555

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$808,314.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2010-04-05 
$45,463.00 
$45,463.00 
$0.00 
Equity 
3
2009-12-23 
$239,308.00 
$239,308.00 
$0.00 
Equity 
2
2009-12-07 
$480,183.00 
$480,183.00 
$0.00 
Equity 
1
2009-06-24 
$43,360.00 
$43,360.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MERRILL 
 
BIEL 
DIRECTOR
ONDINE BIOPHARMA CORP   |  ASPYRIAN THERAPEUTICS, INC.   |  RAKUTEN ASPYRIAN, INC.
MICHAEL 
 
CRANE 
DIRECTOR
ONDINE BIOPHARMA CORP   |  HYPERION LIFE FUNDS II PLC - HYPERION LIFE FUND II-A   |  ZETTICS, INC.   |  NAVIGATE SURGICAL TECHNOLOGIES INC.   |  LIFE OPPORTUNITY FUND I, LP   |  LIFE OPPORTUNITY I FEEDER, LP   |  LIFE OPPORTUNITY FEEDER I, LP
CAROLYN 
 
CROSS 
EXECUTIVE OFFICER, DIRECTOR
ONDINE BIOPHARMA CORP
THOMAS 
 
DAWSON 
EXECUTIVE OFFICER
ONDINE BIOPHARMA CORP
WILLIAM 
 
HARPER 
EXECUTIVE OFFICER
ONDINE BIOPHARMA CORP   |  BELL COPPER CORP   |  PINNACLE EXHIBITS HOLDINGS II, LLC
TERENCE 
 
HOLLAND 
DIRECTOR
ONDINE BIOPHARMA CORP
NICHOLAS 
 
LOEBEL 
EXECUTIVE OFFICER
ONDINE BIOPHARMA CORP
NICOLAS 
 
LOEBEL 
EXECUTIVE OFFICER
ONDINE BIOPHARMA CORP
MARGARET 
 
SHAW 
DIRECTOR
ONDINE BIOPHARMA CORP
COLIN 
 
WATT 
DIRECTOR
ONDINE BIOPHARMA CORP   |  LYNDEN ENERGY CORP   |  FULLER CAPITAL CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-04-07
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2010-04-05 
2009-12-29
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-12-23 
2009-12-21
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-12-07 
2009-09-11
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-06-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#